Dioscorea bulbifera L.-induced hepatotoxicity and involvement of metabolic activation of furanoterpenoids.

IF 3.4 2区 医学 Q2 PHARMACOLOGY & PHARMACY
Drug Metabolism Reviews Pub Date : 2020-11-01 Epub Date: 2020-08-06 DOI:10.1080/03602532.2020.1800724
Hui Li, Ying Peng, Jiang Zheng
{"title":"<i>Dioscorea bulbifera</i> L.-induced hepatotoxicity and involvement of metabolic activation of furanoterpenoids.","authors":"Hui Li,&nbsp;Ying Peng,&nbsp;Jiang Zheng","doi":"10.1080/03602532.2020.1800724","DOIUrl":null,"url":null,"abstract":"<p><p>The rhizome of <i>Dioscorea bulbifera</i> L. (DBL) is a popular traditional herb in the treatment of goiters, breast lumps, and tumors. Unfortunately, DBL can give rise to severe hepatotoxicity. More than 100 cases of liver injury, due to the usage of DBL in China, have been reported in the past half-century. The main toxic components of DBL are furanoditerpenoids diosbulbin B (DSB) as well as 8-epidiosbulbin E (EEA). This toxic effect requires metabolic oxidation of the furan ring mediated by cytochrome P450 enzymes, and the P450 3A subfamily is the main enzyme responsible for the reported hepatotoxicity. <i>cis</i>-Enedial intermediates resulting from furan ring oxidation can react with nucleophilic sites of macromolecules, such as protein and DNA, which may trigger the toxicities. This review illustrates the liver injury induced by DBL including metabolic activation of DSB and EEA, the essential components responsible for DBL-induced hepatotoxicity, along with biochemical mechanisms of their toxic actions. It will facilitate the development of approaches to prevent and intervene in liver injury induced by DBL for its safe use in clinical practice.</p>","PeriodicalId":11307,"journal":{"name":"Drug Metabolism Reviews","volume":"52 4","pages":"568-584"},"PeriodicalIF":3.4000,"publicationDate":"2020-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/03602532.2020.1800724","citationCount":"12","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug Metabolism Reviews","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/03602532.2020.1800724","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2020/8/6 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 12

Abstract

The rhizome of Dioscorea bulbifera L. (DBL) is a popular traditional herb in the treatment of goiters, breast lumps, and tumors. Unfortunately, DBL can give rise to severe hepatotoxicity. More than 100 cases of liver injury, due to the usage of DBL in China, have been reported in the past half-century. The main toxic components of DBL are furanoditerpenoids diosbulbin B (DSB) as well as 8-epidiosbulbin E (EEA). This toxic effect requires metabolic oxidation of the furan ring mediated by cytochrome P450 enzymes, and the P450 3A subfamily is the main enzyme responsible for the reported hepatotoxicity. cis-Enedial intermediates resulting from furan ring oxidation can react with nucleophilic sites of macromolecules, such as protein and DNA, which may trigger the toxicities. This review illustrates the liver injury induced by DBL including metabolic activation of DSB and EEA, the essential components responsible for DBL-induced hepatotoxicity, along with biochemical mechanisms of their toxic actions. It will facilitate the development of approaches to prevent and intervene in liver injury induced by DBL for its safe use in clinical practice.

黄薯蓣诱导的肝毒性及其与呋喃萜类代谢激活的关系。
薯蓣根茎(DBL)是治疗甲状腺肿、乳房肿块和肿瘤的一种流行的传统草药。不幸的是,DBL可引起严重的肝毒性。在过去的半个世纪里,中国已经报道了100多例因使用DBL而导致的肝损伤。DBL的主要毒性成分为呋喃二萜薯蓣皂苷B (DSB)和8-附属物薯蓣皂苷E (EEA)。这种毒性作用需要细胞色素P450酶介导的呋喃环的代谢性氧化,而P450 3A亚家族是报道的肝毒性的主要酶。呋喃环氧化产生的顺式内酯中间体可与大分子(如蛋白质和DNA)的亲核位点发生反应,从而引发毒性。本文综述了DBL引起的肝损伤,包括DSB和EEA的代谢激活,以及它们毒性作用的生化机制。DSB和EEA是DBL引起肝毒性的主要成分。这将促进DBL肝损伤预防和干预方法的发展,促进DBL在临床中的安全应用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Drug Metabolism Reviews
Drug Metabolism Reviews 医学-药学
CiteScore
11.10
自引率
1.70%
发文量
21
审稿时长
1 months
期刊介绍: Drug Metabolism Reviews consistently provides critically needed reviews of an impressive array of drug metabolism research-covering established, new, and potential drugs; environmentally toxic chemicals; absorption; metabolism and excretion; and enzymology of all living species. Additionally, the journal offers new hypotheses of interest to diverse groups of medical professionals including pharmacologists, toxicologists, chemists, microbiologists, pharmacokineticists, immunologists, mass spectroscopists, as well as enzymologists working in xenobiotic biotransformation.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信